Bausch & Lomb (TSX:BLCO) Gross Profit : C$3,373 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Gross Profit?

Bausch & Lomb's gross profit for the three months ended in Dec. 2023 was C$955 Mil. Bausch & Lomb's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was C$3,373 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Bausch & Lomb's gross profit for the three months ended in Dec. 2023 was C$955 Mil. Bausch & Lomb's Revenue for the three months ended in Dec. 2023 was C$1,574 Mil. Therefore, Bausch & Lomb's Gross Margin % for the quarter that ended in Dec. 2023 was 60.70%.

Bausch & Lomb had a gross margin of 60.70% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 6 years, the highest Gross Margin % of Bausch & Lomb was 64.88%. The lowest was 59.69%. And the median was 61.69%.

Warning Sign:

Bausch & Lomb Corp gross margin has been in long-term decline. The average rate of decline per year is -1.6%.

Bausch & Lomb Gross Profit Historical Data

The historical data trend for Bausch & Lomb's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Gross Profit Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Profit

Get a 7-Day Free Trial

3,227.72

2,724.47

2,941.44

3,055.27

3,359.37

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Profit	Get a 7-Day Free Trial											782.50	764.88	821.08	832.16	955.22

Competitive Comparison of Bausch & Lomb's Gross Profit

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch & Lomb's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's Gross Profit distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's Gross Profit falls into.

Bausch & Lomb Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Bausch & Lomb's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	5562.274	-	2202.908
	=	3,359

Bausch & Lomb's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	1573.697	-	618.478
	=	955

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$3,373 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Bausch & Lomb's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	955	/	1573.697
	=	60.70 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Bausch & Lomb (TSX:BLCO) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bausch & Lomb had a gross margin of 60.70% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Bausch & Lomb Gross Profit Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.